XML 82 R20.htm IDEA: XBRL DOCUMENT v3.20.1
EARNINGS PER SHARE
3 Months Ended
Mar. 31, 2020
EARNINGS PER SHARE  
EARNINGS PER SHARE

14. EARNINGS PER SHARE

On October 8, 2019, upon emergence from chapter 11 bankruptcy, the Predecessor Company’s equity was cancelled and new equity was issued. Refer to Note 2, “Reorganization,” for further details.

The following represents the calculation of earnings (loss) per share (in thousands, except per share amounts):

 

 

 

 

 

 

 

 

 

 

 

 

Successor

 

 

Predecessor

 

 

 

Three Months

 

 

Three Months

 

 

 

Ended

 

 

Ended

 

 

    

March 31, 2020

  

  

March 31, 2019

    

Basic:

 

 

 

 

 

 

 

 

Net income (loss)

 

$

114,491

 

 

$

(336,559)

 

Weighted average basic number of common shares outstanding

 

 

16,204

 

 

 

158,549

 

Basic net income (loss) per share of common stock

 

$

7.07

 

 

$

(2.12)

 

Diluted:

 

 

 

 

 

 

 

 

Net income (loss)

 

 

114,491

 

 

 

(336,559)

 

 

 

 

 

 

 

 

 

 

Weighted average basic number of common shares outstanding

 

 

16,204

 

 

 

158,549

 

Common stock equivalent shares representing shares issuable upon:

 

 

 

 

 

 

 

 

Exercise of Predecessor stock options

 

 

 —

 

 

 

Anti-dilutive

 

Exercise of Predecessor warrants

 

 

 —

 

 

 

Anti-dilutive

 

Vesting of Predecessor restricted shares

 

 

 —

 

 

 

Anti-dilutive

 

Exercise of Successor Series A Warrants

 

 

Anti-dilutive

 

 

 

 —

 

Exercise of Successor Series B Warrants

 

 

Anti-dilutive

 

 

 

 —

 

Exercise of Successor Series C Warrants

 

 

Anti-dilutive

 

 

 

 —

 

Exercise of Successor stock options

 

 

Anti-dilutive

 

 

 

 —

 

Vesting of Successor restricted share units

 

 

Anti-dilutive

 

 

 

 —

 

Weighted average diluted number of common shares outstanding

 

 

16,204

 

 

 

158,549

 

Diluted net income (loss) per share of common stock

 

$

7.07

 

 

$

(2.12)

 

 

Common stock equivalents, including warrants, options and restricted stock units, totaling 7.3 million shares for the three months ended March 31, 2020 (Successor) were not included in the computation of diluted earnings per share of common stock because the effect would have been anti-dilutive.

Common stock equivalents, including stock options, restricted shares and warrants, totaling 14.9 million shares for the three months ended March 31, 2019 (Predecessor) were not included in the computation of diluted earnings per share of common stock because the effect would have been anti-dilutive due to the net loss.